255 related articles for article (PubMed ID: 16333005)
1. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.
Jessup JM; Stewart A; Greene FL; Minsky BD
JAMA; 2005 Dec; 294(21):2703-11. PubMed ID: 16333005
[TBL] [Abstract][Full Text] [Related]
2. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
[TBL] [Abstract][Full Text] [Related]
3. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
[TBL] [Abstract][Full Text] [Related]
4. Toxicity and effects of adjuvant therapy in colon cancer: results of the German prospective, controlled randomized multicenter trial FOGT-1.
Staib L; Link KH; Beger HG;
J Gastrointest Surg; 2001; 5(3):275-81. PubMed ID: 11419451
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for colon cancer in the new millenium.
Rao S; Cunningham D
Scand J Surg; 2003; 92(1):57-64. PubMed ID: 12705552
[TBL] [Abstract][Full Text] [Related]
6. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
7. Progress in the adjuvant treatment of colon cancer: has it influenced clinical practice?
Van Cutsem E; Costa F
JAMA; 2005 Dec; 294(21):2758-60. PubMed ID: 16333012
[No Abstract] [Full Text] [Related]
8. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer.
Iwashyna TJ; Lamont EB
J Clin Oncol; 2002 Oct; 20(19):3992-8. PubMed ID: 12351596
[TBL] [Abstract][Full Text] [Related]
9. Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting.
Morris M; Platell C; McCaul K; Millward M; van Hazel G; Bayliss E; Trotter J; Ransom D; Iacopetta B
Int J Colorectal Dis; 2007 Aug; 22(8):887-95. PubMed ID: 17235506
[TBL] [Abstract][Full Text] [Related]
10. North Central Cancer Treatment Group--Mayo Clinic trials in colon cancer.
O'Connell MJ
Semin Oncol; 2001 Feb; 28(1 Suppl 1):4-8. PubMed ID: 11273589
[TBL] [Abstract][Full Text] [Related]
11. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
12. A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
[TBL] [Abstract][Full Text] [Related]
13. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer.
Sundararajan V; Mitra N; Jacobson JS; Grann VR; Heitjan DF; Neugut AI
Ann Intern Med; 2002 Mar; 136(5):349-57. PubMed ID: 11874307
[TBL] [Abstract][Full Text] [Related]
14. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
[TBL] [Abstract][Full Text] [Related]
15. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.
Porschen R; Bermann A; Löffler T; Haack G; Rettig K; Anger Y; Strohmeyer G;
J Clin Oncol; 2001 Mar; 19(6):1787-94. PubMed ID: 11251010
[TBL] [Abstract][Full Text] [Related]
16. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.
McCollum AD; Catalano PJ; Haller DG; Mayer RJ; Macdonald JS; Benson AB; Fuchs CS
J Natl Cancer Inst; 2002 Aug; 94(15):1160-7. PubMed ID: 12165641
[TBL] [Abstract][Full Text] [Related]
18. Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation.
Davidoff AJ; Rapp T; Onukwugha E; Zuckerman IH; Hanna N; Pandya N; Mullins CD
Med Care; 2009 Dec; 47(12):1229-36. PubMed ID: 19786906
[TBL] [Abstract][Full Text] [Related]
19. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group.
Lancet; 2000 May; 355(9215):1588-96. PubMed ID: 10821362
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]